Study the polymorphism of CYP3A5 and CYP3A4 loci in Iranian population with laryngeal squamous cell carcinoma

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 5443-5448

  Azarpira, Negar ^a,b   Ashraf, Mohamad Javad ^b   Khademi, Bigan ^b   Darai, Masumeh ^a   Hakimzadeh, Afsoon ^b   Abedi, Elham ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CYP3A4; CYP3A5; Larynx; Polymorphisms; Squamous cell carcinoma

Indexed keywords

PROTEIN P53;

ALLELE; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOCHROME P450 3A4 GENE; CYTOCHROME P450 3A5 GENE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; IRAN; LARYNX CARCINOMA; MALE; ONCOGENE; POLYMORPHIC LOCUS; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP3A; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC LOCI; GENETICS, POPULATION; HUMANS; IRAN; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855244864     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0699-0     Document Type: Article

References (36)

1. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S (1998) Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18(6B):4779-4786 (Pubitemid 29042060)
2. Rutt AL, Hawkshaw MJ, Sataloff RT (2010) Laryngeal cancer in patients younger than 30 years: a review of 99 cases. Ear Nose Throat J 89(4):189-192
3. Ashraf MJ, Maghbul M, Azarpira N, Khademi B (2010) Expression of Ki67 and P53 in primary squamous cell carcinoma of the larynx. Indian J Pathol Microbiol 53(4):661-665
4. Nelson DR, Koymans L, Kamataki T et al (1996) P450 super-family: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6(1):1-42 (Pubitemid 26096749)
5. Patten CJ, Smith TJ, Friesen MJ, Tynes RE, Yang CS, Murphy SE (1997) Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N0-nitrosonornicotine a-hydroxylation by human liver microsomes. Carcinogenesis 18(8):1623-1630 (Pubitemid 28134788)
6. Gonzalez FJ (1997) The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility. Reprod Toxicol 11(2-3): 397-412 (Pubitemid 27180651)
7. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG (2005) CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 26(12):2207-2212 (Pubitemid 41672209)
8. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Ghoneim MA, Au WW (1997) The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer. Cancer Lett 119(1):115-122 (Pubitemid 27464673)
9. Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF (2011) Cytochrome P450 1A1 gene polymorphisms and endo-metrial cancer risk: a meta-analysis. Int J Gynecol Cancer 21(2):323-331
10. Souiden Y, Mahdouani M, Chaieb K, Elkamel R, Mahdouani K (2010) CYP17 gene polymorphism and prostate cancer susceptibility in a Tunisian population. Cancer Epidemiol. doi: 10.1016/j.canep.2010.11.008
11. Pavanello S, B'chir F, Pulliero A, Saguem S, Ben Fraj R, El Aziz Hayouni A, Clonfero E, Mastrangelo G (2007) Interaction between CYP1A2-T2467DELT polymorphism and smoking in adenocarcinoma and squamous cell carcinoma of the lung. Lung Cancer 57(3):266-272 (Pubitemid 47285430)
12. Varzim G, Monteiro E, Silva RA, Fernandes J, Lopes C (2003) CYP1A1 and XRCC1 gene polymorphisms in SCC of the larynx. Eur J Cancer Prev 12(6):495-499
13. Ko Y, Abel J, Harth V, Bröde P, Antony C, Donat S, Fischer HP, Ortiz-Pallardo ME, Thier R, Sachinidis A, Vetter H, Bolt HM, Herberhold C, Brüning T (2001) Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res 61(11):4398-4404 (Pubitemid 32685766)
14. Singh AP, Shah PP, Mathur N, Buters JT, Pant MC, Parmar D (2008) Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Mutat Res 639(1-2): 11-19
15. Neuhaus T, Ko YD, Lorenzen K, Fronhoffs S, Harth V, Brode P, Vetter H, Bolt HM, Pesch B, Bruning T (2004) Association of cytochrome P450 2E1 polymorphisms and head and neck squa-mous cell cancer. Toxicol Lett 151(1):273-282 (Pubitemid 38739050)
16. Tai J, Yang M, Ni X, Yu D, Fang J, Tan W, Huang Z, Wu C, Chen X, Wang G, Zhou W, Chen X, Zhang W, Ma L, Lin D, Han D (2010) Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Cancer Genet Cytogenet 196(1):76-82
17. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K (2005) CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574(1-2):112-123 (Pubitemid 40725973)
18. Tsuchiya N, Satoh S, Tada H, Li Z, Ohyama C, Sato K, Suzuki T, Habuchi T, Kato T (2004) Influence of CYP3A5 and MDR1 polymorphisms on the pharmacokinetics of tacrol-imus in renal transplant recipients. Transplantation 78(8):1182-1187 (Pubitemid 39426437)
19. Hustert E, Haberl M, Burk O, Wolbold R, He YQ, Klein K, Nuessler AC, Neuhaus P, Klattig J, Eiselt R, Koch I, Zibat A, Brockmöller J, Halpert JR, Zanger UM, Wojnowski L (2001) The genetic determinants of the CYP3A5 polymorphism. Pharmaco-genetics 11(9):773-779 (Pubitemid 33151512)
20. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E (2001) Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27(4):383-391 (Pubitemid 32268418)
21. Raucy JL (2003) Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos 31(5):533-539 (Pubitemid 36444161)
22. Kadlubar FF, Berkowitz GS, Delongchamp RR, Wang C, Green BL, Tang G, Lamba J, Schuetz E, Wolff MS (2003) The CYP3A4 1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer. Cancer Epidemiol Biomarkers Prev 12(4):327-331 (Pubitemid 36427993)
23. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (eds) (2002) American Joint Committee on Cancer; American Cancer Society. American Joint Committee on Cancer staging manual, 6th edn. Springer, Philadelphia
24. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, Sobin LH (eds) (1999) Histological typing of lung and pleural tumors, 3rd edn. World Health Organization. World Health Organization International Histological Classification of Tumours, Geneva
25. Gonzales FJ (1992) Human cytochrome P450: problems and prospects. Trends Pharmacol Sci 13(9):346-352
26. Sarikaya D, Bilgen C, Kamataki T, Topcu Z (2006) Comparative cytochrome P450-1A1,-2A6,-2B6,-2C,-2D6,-2E1,-3A5 and-4B1 expressions in human larynx tissue analysed at mRNA level. Biopharm Drug Dispos 27(8):353-359 (Pubitemid 44842297)
27. Lacko M, Oude Ophuis MB, Peters WH, Manni JJ (2009) Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility. Anticancer Res 29(2):753-761
28. Sharifi R, Allameh A, Biramijamal F, Mohammadzadeh SH, Rasmi Y, Tavangar SM, Jamali-Zavarei M (2008) Relationship between genetic polymorphism of glutathione S-transferase-p1 and p53 protein accumulation in Iranian esophageal squamous cell carcinoma patients. Indian J Cancer 45(1):8-12
29. Sun L, König IR, Homann N (2009) Manganese superoxide dismutase (MnSOD) polymorphism, alcohol, cigarette smoking and risk of oesophageal cancer. Alcohol Alcohol 44(4):353-357
30. Tang K, Li Y, Zhang Z, Gu Y, Xiong Y, Feng G, He L, Qin S (2010) The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies. BMC Cancer 10:575
31. Sabitha K, Reddy MV, Jamil K (2010) Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer. Cancer Epidemiol 34(5):587-592
32. Unal ZN, Unal M, Baǧdatoǧlu OT, Polat G, Atik U (2008) Genetic polymorphism of VEGF-1154 (A/G) in laryngeal squa-mous cell carcinoma. Arch Med Res 39(2):209-211 (Pubitemid 350299625)
33. Khademi B, Razmkhah M, Erfani N, Gharagozloo M, Ghaderi A (2008) SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathol Oncol Res 14(1):45-50
34. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B (2008) Association of interleukin-6 (-174GC) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study. Clin Immunol 128(2):199-204
35. Ruwali M, Parmar D (2010) Association of functionally important polymorphisms in cytochrome P450s with squamous cell carcinoma of head and neck. Indian J Exp Biol 48(7):651-665
36. Lu D, Yu X, Du Y (2010) Meta-analyses of the effect of cyto-chrome P450 2E1 gene polymorphism on the risk of head and neck cancer. Mol Biol Rep. doi:10.1007/s11033-010-0375-9